PT  - JOURNAL ARTICLE
AU  - DeVolld, Trate
AU  - Rivard, Kaitlyn R.
TI  - RSV immunization in adults and children: A practical guide for clinicians
AID  - 10.3949/ccjm.91.s1.03
DP  - 2024 Sep 01
TA  - Cleveland Clinic Journal of Medicine
PG  - S11--S18
VI  - 91
IP  - 9 suppl 1
4099  - http://www.ccjm.org/content/91/9_suppl_1/S11.short
4100  - http://www.ccjm.org/content/91/9_suppl_1/S11.full
SO  - Cleve Clin J Med2024 Sep 01; 91
AB  - In 2023 and 2024, 3 vaccines were approved by the US Food and Drug Administration (FDA) against respiratory syncytial virus (RSV) in adults. In addition, the first long-acting RSV monoclonal antibody for infants and young children was approved. This review provides clinicians with practical guidance to navigate this new era of RSV prevention.